User profiles for Mazzen Hassanain
Mazen HassanainKing Saud University Verified email at ksu.edu.sa Cited by 4264 |
[HTML][HTML] Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience
AA Algaissi, NK Alharbi, M Hassanain… - Journal of infection and …, 2020 - Elsevier
Nearly four months have passed since the emergence of the severe acute respiratory
syndrome-coronavirus-2 (SARS-CoV-2), which caused the rapidly spreading Coronavirus Disease …
syndrome-coronavirus-2 (SARS-CoV-2), which caused the rapidly spreading Coronavirus Disease …
[HTML][HTML] Vaccines and therapeutics for immunocompromised patients with COVID-19
…, C Batista, YB Amor, O Ergonul, M Hassanain… - …, 2023 - thelancet.com
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to severe …
This diverse group is at increased risk for impaired vaccine responses, progression to severe …
[HTML][HTML] Operation Warp Speed: implications for global vaccine security
Several global efforts are underway to develop COVID-19 vaccines, and interim analyses
from phase 3 clinical testing have been announced by nine organisations: Pfizer, the …
from phase 3 clinical testing have been announced by nine organisations: Pfizer, the …
[HTML][HTML] Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics
Comment www. thelancet. com Vol 397 February 13, 2021 563 20% of the vaccine needs of
participating countries. 4 Most low-income and middle-income countries (LMICs) face …
participating countries. 4 Most low-income and middle-income countries (LMICs) face …
[HTML][HTML] Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic
A Lancet Commission for COVID-19 task force is shaping recommendations to achieve
vaccine and therapeutics access, justice, and equity. This includes ensuring safety and …
vaccine and therapeutics access, justice, and equity. This includes ensuring safety and …
Clostridium difficile colitis: increasing incidence, risk factors, and outcomes in solid organ transplant recipients
…, N Giannetti, R Cecere, M Hassanain… - …, 2012 - journals.lww.com
Background Clostridium difficile-associated diarrhea (CDAD) is an increasingly important
diagnosis in solid organ transplant recipients, with rising incidence and mortality. We describe …
diagnosis in solid organ transplant recipients, with rising incidence and mortality. We describe …
[HTML][HTML] Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 vaccines and therapeutics Task force members
To date, just over 100 million COVID-19 immunizations have been administered, led by the
United States accounting for more than onethird (35 million), followed by China (24 million) …
United States accounting for more than onethird (35 million), followed by China (24 million) …
[HTML][HTML] The silent and dangerous inequity around access to COVID-19 testing: a call to action
The COVID-19 pandemic is a public health crisis of unprecedented proportions. Despite
unparalleled rates of vaccination and mass testing in certain parts of the world, the virus rages …
unparalleled rates of vaccination and mass testing in certain parts of the world, the virus rages …
Tumor heterogeneity predicts metastatic potential in colorectal cancer
…, J Kim, HU Cha, M Alotaibi, YB Cho, M Hassanain… - Clinical Cancer …, 2017 - AACR
Purpose: Tumors continuously evolve to maintain growth; secondary mutations facilitate this
process, resulting in high tumor heterogeneity. In this study, we compared mutations in …
process, resulting in high tumor heterogeneity. In this study, we compared mutations in …
[HTML][HTML] Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases
…, P Kavan, S Al-Abbad, P Chaudhury, M Hassanain… - HPB, 2012 - Elsevier
Objectives Portal vein embolization (PVE) can facilitate the resection of previously unresectable
colorectal cancer (CRC) liver metastases. Bevacizumab is being used increasingly in …
colorectal cancer (CRC) liver metastases. Bevacizumab is being used increasingly in …